Our mission is to improve the quality of life for BIPOC who are affected by IBD, Digestive Disorders and associated Chronic Illnesses; through Community, Research, Education, and Advocacy.
2025 marked 5 years that COGI's been an official organization. What was built as a Facebook community turned into a broader mission to get our community diagnosed, to educate patients, caregivers, etc., and spread awareness around digestive diseases. Here are our 2025 highlights!
Pfizer is proud to support Color of Gastrointestinal Illnesses (COGI). Because of our commitment to gastrointestinal care, we recognize the critical need to address healthcare disparities for patients with inflammatory bowel diseases (IBD).
When Damon, a Detroit native now living in the Atlanta area, noticed swelling in his toes, he dismissed it. Within a day, the swelling spread, and he knew something was wrong. Trusting his instincts, he saw a doctor — a decision that changed his life.
The Voices of EOE Network is made up of dedicated ambassadors who inform and inspire others through their personal journeys.
COGI had the incredible opportunity to represent our community at the DDNC Public Policy Forum, where we engaged in vital discussions surrounding healthcare and policy advocacy.
COGI urged the Virginia Governor to veto a recently passed bill creating a Prescription Drug Affordability Board, HB 1724.
On February 10, 2025, COGI provided comments to the Virginia legislature highlighting our concerns about legislation to create a Prescription Drug Affordability Board, HB 1724...
On February 4, 2025, Color of Gastrointestinal Illnesses sent a letter to the Maryland legislature expressing concerns about legislation being considered by the committees of jurisdiction to expand the work of the Prescription Drug Affordability Board.
COGI Calls on CMS to Protect Decisions Between Doctors and Patients by Covering Medications for Obesity and Ensuring Access to Prescribed Treatments
Never miss an update. Receive periodic emails from us, and cancel at any time.
